The Kogan share price has soared 70% in 2023. Here's why it could still be a buy

Is it still a good time to go shopping for Kogan shares?

| More on:
A mature age woman with a groovy short haircut and glasses, sits at her computer, pen in hand thinking about information she is seeing on the screen.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Kogan.com Ltd (ASX: KGN) share price has done exceptionally well since the start of 2023, rising by more than 70%, as we can see on the chart below.

There are a couple of things to say about this that can also be applied to any business that's seeing a strong rise in the share price.

Just because something has gone up doesn't automatically mean that it's expensive.

However, I'd also say a valuation can't keep going up forever because a company's price/earnings (P/E) ratio needs to make sense. When businesses provide financial updates, this can challenge or delight investor perceptions of what's going on.

Good times return for the Kogan share price

It is curious that during a period of rising interest rates – which, in theory, hurt Kogan's customers and valuation – investors have bid up the e-commerce company's valuation.

Kogan's profitability was seriously harmed when it was caught with too much inventory following the strongest period of online shopping demand during COVID-19. The end of lockdowns meant many shoppers returned to normal for bricks and mortar retailers. This led to such a large hit to Kogan's profit that it reported losses.

Kogan recently gave an update for the second half of FY23 which showed that while gross sales declined 22.5% year over year to $373.7 million, its gross profit margin improved by nine percentage points to 34.4%. This resulted in gross profit only declining 3.6% to $73.6 million.

Adjusted earnings before interest, tax, depreciation and amortisation (EBITDA) increased $9.6 million year over year to $11.2 million. At the same time, adjusted earnings before interest and tax (EBIT) rose $11.3 million to $3 million (up from a loss of $8.3 million). I think this is good for the Kogan share price.

Why we can remain positive

While the sales decline is disappointing, it's great to see profit growth has returned because profit is what investors usually focus on to value a business.

The bottom line is projected to improve in each of FY23, FY24, and FY25. While it would be preferable the business would be making more profit than it currently is, the trends are looking positive.

Kogan First members, those in Kogan's customer loyalty program, rose to 401,000 as at 30 June 2023. That's up from 372,000 as of 30 June 2022. The company had 408,000 Kogan First members as of 26 July 2023. Not only are these customers generating membership fees for Kogan, but they hopefully signal a future increase in revenue if they collectively spend more on the website.

The company has significantly improved its inventory position, which had fallen to $68.2 million as of 30 June 2023. This was an improvement of more than 57% since 30 June 2022. It seems it has completed the right-sizing of inventory to the current levels of demand.  

To me, if Kogan can keep growing earnings then it could continue exciting investors. That said, I don't expect the next seven months to be as good as the last seven for the Kogan share price, partly because it has already gone through a significant recovery.

Motley Fool contributor Tristan Harrison has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Kogan.com. The Motley Fool Australia has positions in and has recommended Kogan.com. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Opinions

A doctor or medical expert in COVID protection adjusts her glasses, indicating growth or strong share price movement in ASX medical, biotech and health companies
Opinions

Forget CSL shares, I'd buy this booming biotech stock instead

This ASX biotech stock has caught my eye this year.

Read more »

A medical researcher rests his forehead on his fist with a dejected look on his face while sitting behind a scientific microscope with another researcher's hand on his shoulder as if giving comfort.
Healthcare Shares

Telix Pharmaceuticals shares crash 58% from their peak: Buying opportunity or time to sell up?

The biopharmaceutical company's shares are tipped to soar next year.

Read more »

People with their hands underneath each other's hands holding a plant.
Growth Shares

2 ASX growth shares I'd buy today for growth and income

Both of these businesses are delivering excellent progress.

Read more »

Smiling woman with her head and arm on a desk holding $100 notes out, symbolising dividends.
Dividend Investing

1 ASX dividend stock down 17% I'd buy right now

I’d happily do some pre-Christmas portfolio shopping with this ASX dividend stock.

Read more »

Green arrow with green stock prices symbolising a rising share price.
Opinions

2 ASX shares to buy and hold for the next decade

I’m backing these ASX shares as long-term buys.

Read more »

a hand reaches out with australian banknotes of various denominations fanned out.
Opinions

2 incredible ASX shares I'd buy with $2,000 right now

These investments have global growth potential…

Read more »

Australian dollar notes in the pocket of a man's jeans, symbolising dividends.
Opinions

I'd buy this ASX dividend stock in any market

I’m planning to buy plenty more of this ASX stock in the coming months…

Read more »

Person with a handful of Australian dollar notes, symbolising dividends.
Dividend Investing

3 Aussie passive income stocks delivering decades upon decades of dividends

Income-focused investors could benefit from these stocks.

Read more »